Coloplast A/S (CLPBF)

OTCMKTS · Delayed Price · Currency is USD
109.11
-3.43 (-3.05%)
Dec 23, 2024, 4:00 PM EST
-4.78%
Market Cap 24.90B
Revenue (ttm) 4.04B
Net Income (ttm) 755.59M
Shares Out n/a
EPS (ttm) 3.36
PE Ratio 32.95
Forward PE n/a
Dividend 2.41 (2.14%)
Ex-Dividend Date Dec 6, 2024
Volume 100
Open 109.11
Previous Close 112.54
Day's Range 109.11 - 109.11
52-Week Range 108.33 - 143.15
Beta 0.33
Analysts n/a
Price Target n/a
Earnings Date Feb 4, 2025

About Coloplast

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the B... [Read more]

Sector Healthcare
Founded 1954
Employees 16,639
Stock Exchange OTCMKTS
Ticker Symbol CLPBF
Full Company Profile

Financial Performance

In 2024, Coloplast's revenue was 27.03 billion, an increase of 10.33% compared to the previous year's 24.50 billion. Earnings were 5.05 billion, an increase of 5.62%.

Financial numbers in DKK Financial Statements

News

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons.

12 days ago - GlobeNewsWire

Coloplast A/S - Decisions at the Annual General Meeting 2024

Today, 5 December 2024, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted: The annual report for the financial year 2023/24 was approved. Distribution of y...

18 days ago - GlobeNewsWire

Coloplast divests core Skin Care product portfolio

The divestment is part of a strategic initiative to simplify business operations and improve profitability in the Advanced Wound Care business area.

20 days ago - GlobeNewsWire

Coloplast A/S - Notice of Annual General Meeting 2024

The Annual General Meeting of Coloplast A/S will be held on Thursday, 5 December 2024 at 3:30 pm CET at the premises of Coloplast A/S, Holtedam 3 in Humlebæk (the Aage Louis-Hansen Auditorium), Humleb...

6 weeks ago - GlobeNewsWire

Coloplast A/S (CLPBF) Q4 2024 Earnings Call Transcript

Coloplast A/S (OTCPK:CLPBF) Q4 2024 Earnings Conference Call November 5, 2024 5:00 AM ETCompany ParticipantsNicholas Seibert - Vice President of Corporate...

6 weeks ago - Seeking Alpha

Coloplast Finance B.V. - Annual Report, 2023/24

Hereby please find the Annual Report 2023/24 for the group of Coloplast A/S. Attachment 07_2024_Annual_Report_2023-24

7 weeks ago - GlobeNewsWire

Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24

Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24 FY 2023/24 organic growth of 8% and 27% EBIT margin1. Reported revenue in DKK grew 10% to DKK 27,030 million.

7 weeks ago - GlobeNewsWire

Coloplast A/S - Full-Year Financial Results 2023/24

2023/24 Announcement of full-year financial results 1 October 2023 - 30 September 2024 Coloplast delivered Q4 organic growth of 8% and an EBIT margin1 of 26%, which was negatively impacted by extraord...

7 weeks ago - GlobeNewsWire

Coloplast A/S - Announcement no. 05/2024 - Coloplast expands Executive Leadership Team

Coloplast expands Executive Leadership Team Today, the Board of Directors have decided to expand the Coloplast Executive Leadership Team (ELT) with immediate effect.

7 weeks ago - GlobeNewsWire

Coloplast A/S - FY 2023/24 Earnings Release - Invitation for conference call on 5 November 2024 at 11.00 CET

Tuesday, 5 November 2024 at 11.00 – 12.00 CET In connection with the publication of Coloplast's interim financial results for FY 2023/24 the company will host a conference call to present the financia...

2 months ago - GlobeNewsWire

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

3 months ago - GlobeNewsWire

Coloplast A/S - Financial Calendar 2024-25

Please see enclosed pdf. For more information and calendar invitations for upcoming events, please visit: https://investor.coloplast.com/investor-relations/financial-calendar-and-events/ Kind regards,...

3 months ago - GlobeNewsWire

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons.

3 months ago - GlobeNewsWire

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons.

3 months ago - GlobeNewsWire

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Please see enclosed pdf.   Attachment 03092024_trading_in_shares_ASL

4 months ago - GlobeNewsWire

Coloplast A/S - Interim Financial Report, 9M 2023/24

9M 2023/24 Interim financial results, 9M 2023/24 1 October 2023 - 30 June 2024 Coloplast delivered 8% organic growth and an EBIT margin1) of 27% in Q3, with 11% growth in absolute EBIT1). Reported rev...

4 months ago - GlobeNewsWire

Coloplast A/S - Invitation to Coloplast's Meet the Management event on 6 June 2024 (gentle reminder)

The event will take place on Thursday, 6 June 2024 at Coloplast's Headquarters Holtedam 3, 3050 Humlebaek, Denmark from 11.30 - 18.00 CEST (Central European Summer Time)

7 months ago - GlobeNewsWire

Coloplast expands its Luja™ portfolio with next generation catheter for women

The female intermittent catheter enables complete bladder emptying in one free flow1, aiming to reduce the risk of urinary tract infections2.

8 months ago - GlobeNewsWire

Coloplast A/S (CLPBF) Q2 2023/2024 Earnings Call Transcript

Coloplast A/S (OTCPK:CLPBF) Q2 2023/2024 Earnings Conference Call May 7, 2024 3:00 AM ET Company Participants Kristian Villumsen - President and CEO Anders Lonning-Skovgaard - EVP and CFO Conference C...

8 months ago - Seeking Alpha

Coloplast Finance B.V. - Interim Financial Report, H1 2023/24

H1 2023/24 Interim financial results, H1 2023/24 1 October 2023 - 31 March 2024 Coloplast delivered a solid Q2 with 8% organic growth and an EBIT margin1) of 27%.  Reported revenue in DKK grew 9% with...

8 months ago - GlobeNewsWire

Coloplast strengthens ostomy care portfolio with three significant product launches

The company has received reimbursement approval in the UK for Heylo™, the world's first digital leakage notification system, and expands its SenSura® Mio ostomy range with two new products.

8 months ago - GlobeNewsWire

Coloplast A/S - Announcement no. 02/2024 - Interim Financial Report, H1 2023/24

H1 2023/24 Interim financial results, H1 2023/24 1 October 2023 - 31 March 2024 Coloplast delivered a solid Q2 with 8% organic growth and an EBIT margin1) of 27%. Reported revenue in DKK grew 9% with ...

8 months ago - GlobeNewsWire

Coloplast A/S (CLPBF) Q1 2023/2024 Earnings Call Transcript

Coloplast A/S (CLPBF) Q1 2023/2024 Earnings Call Transcript

11 months ago - Seeking Alpha